statistiche ricercatore

Continente	#
NA - Nord America	579
AS - Asia	232
SA - Sud America	132
EU - Europa	122
Continente sconosciuto - Info sul continente non disponibili	21
AF - Africa	7
OC - Oceania	1
Totale	1.094

Nazione	#
US - Stati Uniti d'America	561
BR - Brasile	123
SG - Singapore	92
CN - Cina	47
IT - Italia	40
VN - Vietnam	32
DE - Germania	16
HK - Hong Kong	12
FR - Francia	11
GB - Regno Unito	11
FI - Finlandia	10
BD - Bangladesh	9
IQ - Iraq	7
MX - Messico	6
CA - Canada	5
JP - Giappone	5
RU - Federazione Russa	5
CZ - Repubblica Ceca	4
ES - Italia	4
IN - India	4
NL - Olanda	4
PK - Pakistan	4
AR - Argentina	3
BE - Belgio	3
EC - Ecuador	3
SE - Svezia	3
TR - Turchia	3
AE - Emirati Arabi Uniti	2
AZ - Azerbaigian	2
DO - Repubblica Dominicana	2
EG - Egitto	2
JM - Giamaica	2
LB - Libano	2
LT - Lituania	2
PL - Polonia	2
UA - Ucraina	2
ZA - Sudafrica	2
AU - Australia	1
CL - Cile	1
IE - Irlanda	1
IL - Israele	1
JO - Giordania	1
KH - Cambogia	1
KN - Saint Kitts e Nevis	1
KZ - Kazakistan	1
LC - Santa Lucia	1
MA - Marocco	1
MD - Moldavia	1
MK - Macedonia	1
MT - Malta	1
MY - Malesia	1
NP - Nepal	1
OM - Oman	1
PA - Panama	1
PE - Perù	1
PS - Palestinian Territory	1
RS - Serbia	1
SA - Arabia Saudita	1
SN - Senegal	1
TL - Timor Orientale	1
UZ - Uzbekistan	1
VE - Venezuela	1
XK - ???statistics.table.value.countryCode.XK???	1
ZM - Zambia	1
Totale	1.074

Nome	#
Efficacy and safety of B/F/TAF in naïve people with HIV: real life data from the SHiNeSHiC research group	258
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity	156
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients	147
Vaccination and Antiviral Treatment Reduce the Time to Negative SARS-CoV-2 Swab: A Real-Life Study	119
Living with HIV and Getting Vaccinated: A Narrative Review	107
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort	97
New score to predict COVID-19 progression in vaccine and early treatment era: the COVID-19 Sardinian Progression Score (CSPS)	96
Present and future of HIV pre-exposure prophylaxis: a narrative review	36
Bictegravir/emtricitabine/tenofovir alafenamide in people with HIV aged ≥50: low discontinuation rates and favorable metabolic outcomes over 36 months	36
Exploring the impact of Cabotegravir‐Rilpivirine long‐acting on weight gain, body composition and quality of life in adults living with HIV	23
Risk of autochthonous human schistosomiasis transmission in Italy	19
Totale	1.094

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	8	0	0	0	0	0	0	0	0	0	0	4	4
2022/2023	15	2	2	0	1	1	2	0	5	0	1	1	0
2023/2024	32	0	1	1	2	5	12	0	3	0	0	1	7
2024/2025	248	6	1	8	7	8	9	19	57	84	28	12	9
2025/2026	728	28	85	282	64	52	26	55	26	36	35	17	22
2026/2027	63	16	47	0	0	0	0	0	0	0	0	0	0
Totale													1.094